期刊
TRENDS IN CARDIOVASCULAR MEDICINE
卷 31, 期 7, 页码 435-445出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2020.10.002
关键词
Aortic stenosis; Aortic valve; TAVI; Bicuspid aortic valve; Heart failure
TAVI has become a global reality for treating AS, offering a less invasive approach. Recent studies are exploring new indications for TAVI such as asymptomatic severe AS, bicuspid aortic valves, and moderate AS in heart failure patients.
Aortic stenosis (AS) remains one of the most common valvular heart diseases, with enormous impact on patient survival. Over the past years, transcatheter aortic valve implantation (TAVI) has become a reality worldwide, offering a less invasive method to treat AS. Apart from the classical indications for aortic valve disease, recent studies tried to address unanswered questions for TAVI - asymptomatic severe AS, bicuspid aortic valves and moderate AS in patients with heart failure. This review discusses the rationale of those possible indications, pitfalls and current evidence in the medical literature. (c) 2020 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据